Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

Healthcare Cannabis
FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is... see more

Recent & Breaking News (CSE:HUGE)

FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders

Business Wire June 30, 2023

DR. RAZA BOKHARI, FORMER EXECUTIVE CHAIRMAN AND CEO OF FSD PHARMA, FILES TWO ADDITIONAL CLAIMS AGAINST THE COMPANY SEEKING RELIEF AND MONETARY DAMAGES EXCEEDING $30.2 MILLION

PR Newswire June 21, 2023

FSD Pharma Announces Agreement to Grant Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology

Business Wire June 20, 2023

FSD Pharma Appoints Former Ontario Minister of Health Doctor Eric Hoskins to Board of Directors

Business Wire May 25, 2023

FSD Pharma Announces Receipt of Court Action and Update on Spin-Out and Distribution

Business Wire May 12, 2023

FSD Pharma Awarded $2.81 Million in Cost Awards From Dr. Raza Bokhari

Business Wire May 11, 2023

FSD Pharma Completes Dosing of First Cohort in Phase I Clinical Trial of Lucid-MS, a New Drug Candidate for the Treatment of Multiple Sclerosis: Safety Review Committee Recommends Commencing Dosing of Second Cohort

Business Wire May 10, 2023

Sidoti's Micro-Cap Virtual May Conference

Accesswire May 9, 2023

FSD Pharma to Present at Sidoti Virtual Investor Conference May 10-11

Business Wire May 8, 2023

FSD Pharma Achieves Milestone in Completion of Dosing of Sentinel Subjects in First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis

Business Wire April 17, 2023

IIROC Trade Resumption - HUGE

Canada NewsWire April 12, 2023

IIROC Trading Halt - HUGE

Canada NewsWire April 12, 2023

FSD Pharma Announces Plan to Spin-Out Subsidiary as Distribution to Shareholders; Shareholder Meeting Scheduled for June 29, 2023

Business Wire April 12, 2023

FSD Pharma Announces Filing of Year-End 2022 Results

Business Wire March 31, 2023

FSD Pharma Adds Former Celsius Holdings CEO Gerry David to Board of Advisors

Business Wire March 30, 2023

FSD Pharma Announces Its Australian Entity Receives Approval to Proceed With Phase 1 Clinical Trial of Lucid-201, a Candidate for the Potential Treatment of Major Depressive Disorder

Business Wire March 22, 2023

FSD Pharma (Symbol: HUGE) Renews Shareholder Intelligence Services to Investigate Possible Naked Short Selling and Appeals to The Regulators and Oversight Bodies to Look Into The Short Selling Activity Of Its Stock

Business Wire March 14, 2023

FSD Pharma (CSE:HUGE) strengthens advisory board with Shark Tank alumnus

Trevor Abes  February 28, 2023

Original "Shark" and Iconic Entrepreneur Kevin Harrington Joins FSD Pharma Advisory Board

Business Wire February 28, 2023

FSD Pharma Presenting Two Scientific Posters on Preclinical Toxicology and Efficacy Data of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2023 Forum

Business Wire February 21, 2023